What to Know About Guillain Barré Syndrome and Its Link to the Johnson & Johnson Vaccine Prevention 4 hrs ago
Replay Video UP NEXT
The Food and Drug Administration (FDA) announced on July 12 that it is updating the label on the Johnson & Johnson COVID-19 vaccine to include a warning about the risk of developing Guillain-Barré syndrome, (GBS) a rare and sometimes deadly autoimmune disorder in which the body attacks and damages nerves, according to the Centers for Disease Control and Prevention (CDC). © SOPA Images - Getty Images The Johnson & Johnson COVID-19 vaccine has been linked to Guillain Barré Syndrome in rare cases. Experts explain what to know about the condition.
New-york
United-states
Ohio
Prathit-kulkarni
Lewis-nelson
Amesha-adalja
Epstein-barr
Guillain-barr
Richard-watkins
Johnson
Jeffrey-carson
Centers-for-disease